How Supplements Are Regulated in the United States?

Unlike prescription drugs, dietary supplements don’t need FDA approval before they hit the market. Under DSHEA, manufacturers, not the FDA, bear full responsibility for ensuring their products are safe and properly labeled. The FDA can only step in after a problem surfaces, issuing warning letters, mandating recalls, or taking enforcement action against adulterated products. With over 85,000 supplements currently on the U.S. market, understanding the specific rules around labeling, claims, and manufacturing will show you exactly where regulatory risks emerge.

Why Supplements Don’t Need FDA Approval Before Sale

Instead, manufacturers bear full responsibility for ensuring their products are safe and properly labeled. The exception involves new dietary ingredients, which require a 75-day advance notification to FDA with supporting safety information.

FDA supplement oversight activates primarily after products are already available to you. The agency monitors adverse event reports, inspects facilities, and takes enforcement action when safety concerns surface, but only reactively, not preventively. Manufacturers must adhere to 21 CFR 111, which requires establishing specifications for identity, purity, strength, composition, and potential contaminants for every component and finished product. With over 85,000 supplement products estimated to be on the U.S. market, the agency’s limited analytical methods and oversight resources make comprehensive enforcement a significant challenge. Additionally, dietary supplements cannot be marketed to treat, prevent, or cure specific diseases, a restriction that further defines the boundaries of what manufacturers can claim about their products.

What DSHEA Changed About Supplement Regulation in 1994

Here’s what DSHEA specifically altered in dietary supplement regulation United States:

1. Eliminated pre-market approval, you won’t find FDA sign-off required before a supplement hits shelves.
2. Shifted the burden of proof, FDA must now demonstrate a product’s adulteration, not the manufacturer.
3. Expanded the supplement definition, covering vitamins, minerals, herbs, amino acids, and other dietary substances.
4. Permitted structure/function claims, manufacturers can make health-related statements without pre-market review if they’re truthful and not misleading.

How the FDA Monitors Supplements After They Hit Shelves

When safety signals emerge, the agency acts through FDA warning supplements letters, labeling updates, or recalls classified by severity, Class I being the most serious. You’re protected not by pre-market gatekeeping but by enforcement tools deployed after problems surface.

Supplement Labeling Rules Under Federal Regulation

When you pick up a dietary supplement, the label must include a Supplement Facts panel that lists serving size, dietary ingredients, amounts per serving, and percent Daily Values where established, all formatted according to 21 CFR 101.36. You’re also required to see the statement of identity (“Dietary Supplement”) on the principal display panel, along with manufacturer contact information and any applicable warnings. If the product carries a structure/function claim like “supports energy production,” it must also display the DSHEA disclaimer and can’t make disease claims such as “treats hypertension.”

Supplement Facts Panel Requirements

Because dietary supplements don’t undergo pre-market approval, the Supplement Facts panel serves as one of the most critical compliance touchpoints between manufacturers and federal regulators. Understanding how supplements are regulated in the US starts here, this panel is governed by 21 CFR 101.36 and dictates exactly what you’ll find on compliant products versus those flooding the unregulated supplements retail market.

You should verify these four mandatory panel elements:

1. Title formatting: “Supplement Facts” must appear in bold type, larger than all other panel text, spanning full width.
2. Serving declarations: Serving size and servings per container are non-negotiable, aligning with batch manufacturing records.
3. Dietary ingredient listing: Ingredients appear in descending weight order with %DV where established.
4. Other ingredients: Excipients and flavors listed separately below the panel.

Weak convenience store supplement regulation makes self-verification essential.

Permitted Health Claims

Beyond the Supplement Facts panel itself, the claims printed on a dietary supplement label carry their own set of federal requirements, and misunderstanding them is one of the fastest ways a product crosses from compliant to illegal.

You’ll encounter five permissible claim categories: structure/function claims, health claims, qualified health claims, nutrient content claims, and nutrient deficiency disease claims. Structure/function claims, the most common, describe effects on bodily functions without referencing disease. Health claims require FDA authorization under the Significant Scientific Agreement standard; only 12 have been approved since 1990.

You can’t use language like “cures,” “treats,” or “prevents” disease. Even “reduces the risk” demands prior FDA approval. If you’re making structure/function claims, you must notify the FDA within 30 days and display the required disclaimer directly adjacent to each claim.

Structure/Function Claims vs. Disease Claims

When you market a dietary supplement, you can make structure/function claims, statements describing how a nutrient affects normal body processes, like “calcium builds strong bones”, without obtaining FDA pre-approval, though you must notify the agency within 30 days and include a disclaimer that the FDA hasn’t evaluated the claim. You can’t, however, make disease claims that suggest your product diagnoses, cures, treats, or prevents a specific disease, as these require FDA authorization reserved for approved drugs. Understanding this distinction is critical because crossing the line from a permissible structure/function claim into a prohibited disease claim can trigger enforcement actions against your product.

Defining Structure/Function Claims

Although dietary supplements don’t require FDA pre-approval before reaching consumers, manufacturers still face strict rules about the claims they print on labels. Under DSHEA (1994), structure/function claims describe how a nutrient or dietary ingredient affects your body’s normal structure or function, without referencing disease.

You must understand the four core categories these claims cover:

1. Nutrient role claims, e.g., “calcium builds strong bones”
2. Body function claims, e.g., “fiber maintains bowel regularity”
3. General well-being claims, e.g., “supports overall importance”
4. Nutrient deficiency claims, must disclose U.S. prevalence of the condition

These claims don’t imply treatment, mitigation, or cure. If your label crosses into disease-claim territory, you’ve triggered a different regulatory framework entirely. Precision in language isn’t optional, it’s a compliance requirement.

Disease Claims Prohibited

Because the FDA draws a hard legal line between structure/function claims and disease claims, crossing that boundary reclassifies your supplement as a drug, subjecting it to premarket approval requirements you almost certainly haven’t met. If your label suggests your product diagnoses, cures, mitigates, treats, or prevents a disease, you’ve made a drug claim, regardless of your product’s formulation. Understanding the nuances of the FDA approval process for supplements can save you from significant legal repercussions. Many entrepreneurs assume that as long as they avoid overt disease claims, they can freely market their products; however, this is a misconception that can lead to enforcement actions. Properly navigating these regulations is essential to ensure your supplement remains classified appropriately and avoids the costly implications of being classified as a drug.

Claim Type	Example	Status
Structure/Function	“Supports joint flexibility”	Permitted with disclaimer
Disease Claim	“Supports body’s antiviral capabilities”	Prohibited
Implied Disease Claim	“Contains ingredient formerly only available as prescription drug”	Prohibited

Twenty percent of sampled supplements included prohibited disease claims on their labels. You’re responsible for ensuring every claim stays within legal boundaries. Violations trigger enforcement actions, including product removal from the market.

FDA Notification Requirements

If you’re making a structure/function claim on your dietary supplement label, federal law requires you to notify the FDA, but not to obtain its approval. You must submit this notification no later than 30 days after first marketing the product. Electronic submission is available through the COSM ePortal.

Your notification must include:

1. The name and address of the manufacturer, packer, or distributor
2. The exact text of the claim being made
3. The name of the dietary ingredient and the brand-name product bearing the statement
4. Contact information and a signature certifying the claim’s accuracy and substantiation

The FDA reviews submissions and may issue a courtesy objection letter if your claim implies disease treatment, diagnosis, cure, or prevention. You won’t receive confirmation if no objection is raised.

What the FTC Requires for Supplement Ad Claims

The FTC evaluates claims based on how a reasonable consumer interprets them, not your intent. If your ad conveys multiple meanings through text, images, or product naming, you must substantiate every reasonable interpretation.

You’re also required to disclose significant limitations on benefits or safety risks. These disclosures must be clear, conspicuous, and matched to the claim’s modality. They can’t contradict the primary message. Vague qualifiers like “promising” or “preliminary” won’t satisfy FTC standards without more rigorous disclosure.

Why New Supplement Ingredients Face Extra Scrutiny

Advertising compliance only covers part of your regulatory exposure, before you can even promote a supplement containing a new dietary ingredient, federal law requires you to clear a separate premarket safety hurdle with the FDA. Section 413 of the Federal Food, Drug, and Cosmetic Act mandates that you file a New Dietary Ingredient Notification (NDIN) and observe a 75-day review period before marketing.

Before you advertise, you must clear the FDA’s premarket safety gate, or your supplement is automatically adulterated under federal law.

If you skip this step, your product’s automatically deemed adulterated under federal law. Here’s what you’re required to demonstrate:

1. Your ingredient will reasonably be expected to be safe under labeled conditions of use
2. You’ve conducted thorough scientific literature searches on adverse effects
3. You’ve provided a history of use or equivalent safety evidence
4. Your submission is organized, complete, and scientifically supported

Incomplete NDINs receive no evaluation and require resubmission.

Manufacturing Rules Every Supplement Maker Must Follow

Once your New Dietary Ingredient Notification clears the 75-day review window, you’re still not free to manufacture at will, federal law imposes a separate, detailed set of production standards you must satisfy before a single unit ships.

The FDA’s Current Good Manufacturing Practices, codified in 21 CFR Part 111, require you to conduct 100 percent identity testing of dietary ingredients, assign qualified personnel to oversee every production phase, and maintain detailed master manufacturing records. You must register your facility with the FDA and renew that registration biennially.

Each batch must be assayed for consistency against labeled specifications. Your facility must meet strict sanitation standards, and you’re responsible for qualifying suppliers, since raw materials can arrive contaminated with pesticides, heavy metals, or microbiological agents. Non-compliance triggers enforcement action.

What Happens When a Supplement Causes Harm

Even after a manufacturer follows every cGMP requirement in 21 CFR Part 111, a product can still reach consumers and cause harm, and when it does, the recall process becomes the FDA’s primary corrective tool.

When cGMP compliance isn’t enough, the FDA recall process steps in to protect consumers from harm.

You should understand the key triggers that initiate a recall:

1. Undeclared allergens or ingredients, mislabeling that exposes consumers to hidden risks like fish, shellfish, eggs, or wheat.
2. Contamination or adverse reactions, consumer complaints, illness reports, or dosage violations that signal a safety deficiency.
3. FDA inspection findings, violations of FDA-administered laws discovered during facility audits or product testing.
4. Internal quality control failures, issues a firm identifies through its own safety checks or root cause analyses.

You’re expected to notify your local FDA District Recall Coordinator immediately, providing production codes, hazard assessments, and distribution details.

Help Is Available

Making sense of health and wellness information is not always straightforward, and having the right guidance can make all the difference. At Miami Outpatient Detox, we help people connect with licensed detox centers that provide Prescription Stimulant Detox and a range of evidence-based programs for those who are ready to begin their recovery journey. Call (786) 228-8884 to explore available treatment options.

Frequently Asked Questions

Can States Ban Supplements That Are Still Legal Under Federal Law?

Yes, you can face state-level bans on supplements that remain legal federally. States like New York and California have enacted restrictions, including retail limits, age-of-sale laws, and consumer-protection requirements, that go beyond FDA oversight under DSHEA. However, you should monitor H.R.7366, the Dietary Supplement Regulatory Uniformity Act, which would preempt state rules that differ from federal standards. Until Congress acts, you’ll need to comply with both federal and applicable state regulations.

How Do Supplement Regulations in the U.S. Compare to European Standards?

The EU holds supplements to stricter pre-market standards than you’ll find in the U.S. You can’t market a novel ingredient in Europe without EFSA’s scientific evaluation and authorization, while the U.S. relies primarily on post-market enforcement. The EU also sets uniform maximum nutrient levels and requires pre-approved health claims. In contrast, you’re permitted to make structure/function claims in the U.S. without prior FDA approval.

Are Gas Station Psychoactive Supplements Regulated Differently Than Mainstream Dietary Supplements?

No, they aren’t regulated differently, they fall under the same DSHEA framework. However, gas station products exploit this system by labeling psychoactive substances like tianeptine and phenibut as “dietary supplements” despite not meeting the dietary ingredient definition. You should know the FDA doesn’t require pre-market approval for any supplement, so these products reach shelves without safety review. The FDA and states are now issuing bans and warning letters to close these loopholes.

Can Consumers Sue Supplement Companies for Selling Unsafe or Mislabeled Products?

Yes, you can sue supplement companies for selling unsafe or mislabeled products. You’d typically file claims under state consumer protection laws, alleging deceptive labeling, false advertising, or misbranding under the Federal Food, Drug, and Cosmetic Act. You can seek economic damages, medical costs, and injunctive relief to force label corrections. Class actions are common, there were 58 new ones in 2024 alone. FDA Warning Letters often strengthen your case substantially.

Do Dietary Supplement Regulations Apply to Products Sold Online From Overseas?

Yes, U.S. dietary supplement regulations apply to products sold online from overseas. If you’re importing supplements into the U.S., you must comply with FDA’s Foreign Supplier Verification Program, register facilities, follow cGMP standards, and guarantee accurate labeling. You’ll also need a U.S.-based FSVP agent to liaise with FDA. Non-compliance can result in denied entry, recalls, or enforcement actions. The FTC also holds you accountable for deceptive advertising.